On June 18, McKesson declined 3.19% in regular trading, trading at $754.4/share, with turnover of $327 million. The stock came under pressure following a regulatory filing indicating a proposed sale of securities by a significant shareholder.

According to the filing dated June 17, a major shareholder submitted a Report of Proposed Sale of Securities, signaling an intent to reduce their position in McKesson. Such filings typically indicate planned dispositions by insiders or large holders, which can weigh on investor sentiment and trigger near-term selling pressure as the market prices in potential supply overhang.

Within the Health Care Distributors sector, peers also showed mixed performance. Cencora Inc. fell 0.98%, Cardinal Health declined 1.98%, and Henry Schein dropped 0.61%, while AdaptHealth Corp. gained 1.15% and Agape ATP Corp. surged 71.5%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)